These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15519518)

  • 1. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.
    Li Y; Womer RB; Silber JH
    Eur J Cancer; 2004 Nov; 40(16):2445-51. PubMed ID: 15519518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity in children treated for osteosarcoma.
    Lewis MJ; DuBois SG; Fligor B; Li X; Goorin A; Grier HE
    Pediatr Blood Cancer; 2009 Mar; 52(3):387-91. PubMed ID: 19061216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ototoxicity of cisplatin in children with malignant diseases].
    Hadjilaskari P; Fengler R; Hartmann R; Henze G
    Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
    Weissenstein A; Deuster D; Knief A; Zehnhoff-Dinnesen AA; Schmidt CM
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring hearing during ototoxic cisplatin therapy].
    Kluba J; Kluba U; von Specht H; Mittler U
    Padiatr Grenzgeb; 1990; 29(1):19-23. PubMed ID: 2342815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early cisplatin induced ototoxicity profile may predict the need for hearing support in children with medulloblastoma.
    Lafay-Cousin L; Purdy E; Huang A; Cushing SL; Papaioannou V; Nettel-Aguirre A; Bouffet E
    Pediatr Blood Cancer; 2013 Feb; 60(2):287-92. PubMed ID: 23002030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The ototoxicity of cisplatin: a clinical study].
    Vantrappen G; Rector E; Debruyne F
    Acta Otorhinolaryngol Belg; 1990; 44(4):415-21. PubMed ID: 2093285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hearing assessment of children treated with Cisplatin].
    Mniszek J; Bielecki I; Sobol G
    Pol Merkur Lekarski; 2009 Aug; 27(158):105-8. PubMed ID: 19856874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
    Jehanne M; Lumbroso-Le Rouic L; Savignoni A; Aerts I; Mercier G; Bours D; Desjardins L; Doz F
    Pediatr Blood Cancer; 2009 May; 52(5):637-43. PubMed ID: 19148943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.
    Reddel RR; Kefford RF; Grant JM; Coates AS; Fox RM; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):19-23. PubMed ID: 7198012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.
    Kushner BH; Budnick A; Kramer K; Modak S; Cheung NK
    Cancer; 2006 Jul; 107(2):417-22. PubMed ID: 16779793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
    Knight KR; Kraemer DF; Neuwelt EA
    J Clin Oncol; 2005 Dec; 23(34):8588-96. PubMed ID: 16314621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors.
    Gupta AA; Capra M; Papaioannou V; Hall G; Maze R; Dix D; Weitzman S
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):91-4. PubMed ID: 16462581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
    Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.